[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100578739":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":18,"locations":10,"responsibleParty":27,"collaborators":29,"id":33,"slug":34,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":38,"acronym":39,"eligibilityCriteria":40,"healthyVolunteers":35,"sex":41,"minAge":42,"maxAge":10,"enrollmentInfo":43,"targetDuration":46,"studyType":47,"phases":10,"briefSummary":48,"conditions":49,"keywords":52,"overallStatus":58,"whyStopped":10,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":10},{"fullName":5,"class":6},"Ärzteverband Deutscher Allergologen e.V.","OTHER",[8,12,15],{"label":9,"type":10,"description":11,"interventionNames":10},"sinus surgery",null,"all patients who received sinus surgery during the observation period",{"label":13,"type":10,"description":14,"interventionNames":10},"biologic treatment","all patients who are treated with a biologic drug",{"label":16,"type":10,"description":17,"interventionNames":10},"non-biologic, non-surgery","all patients without surgery or biologic treatment during observation period",[19,24],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Jan Hagemann, Dr. med.","CONTACT","+49611308608273","jan.hagemann@allergiezentrum.org",{"name":25,"role":21,"phone":22,"phoneExt":10,"email":26},"Friederike Bärhold, Dr. med.","friederike.baerhold@allergiezentrum.org",{"type":28,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[30],{"name":31,"class":32},"German Society of Otorhinolaryngology, Head and Neck Surgery","UNKNOWN","100578739","the-german-national-crs-registry-genrecrs-clinical-evaluation-of-the-new-european-academy-for-allergy-and-clinical-immunology-eaaci-criteria-for-crswnp-disease-control-remission-and-cure-in-a-real-world-evidence-study-approach-100578739",false,"NCT06815211","The German National CRS Registry (GenreCRS): Clinical Evaluation of the New European Academy for Allergy and Clinical Immunology (EAACI) Criteria for CRSwNP Disease Control, Remission and Cure in a Real-World Evidence Study Approach","A Prospective Study for Real-world Evaluation of the Novel European Academy for Allergy and Clinical Immunology (EAACI) Criteria for Disease Control, Remission and Cure in CRSwNP Utilizing the German National CRS Registry (GENRE CRS)","GenreCRS","Inclusion Criteria:\n\n* Patients above the age of 12 years\n* Patients who are diagnosed with CRS according to internationally valid guidelines (EPOS 2020)\n* Patients who provide written informed consent or by a legal representative\n\nExclusion Criteria:\n\n* Patients below the age of 12 years at initiation\n* Patients who do not provide written consent or withdraw their consent","ALL","12 Years",{"count":44,"type":45},500,"ESTIMATED","1 Year","OBSERVATIONAL","The objective of the study is to establish a registry of patients diagnosed with Chronic Rhinosinusitis with and without Nasal Polyps (CRSwNP\u002FCRSsNP) to collect comprehensive longitudinal real-world evidence from specialised treatment centres in Germany. The primary analysis will concentrate on the treatment efficacy and safety of biologic drugs with a focus on defining disease Control, Remission, and Cure as well as to validate the corresponding clinical evaluation criteria.",[50,51],"Chronic Rhinosinusitis (CRS)","Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps",[53,54,55,56,57],"CRSwNP","CRSsNP","Nasal Polyps","Registry","Patient Reported Outcome Measures (PROM)","NOT_YET_RECRUITING","2025-06-03",{"date":61,"type":62},"2025-06-04","ACTUAL",{"date":64,"type":45},"2025-10",{"date":66,"type":45},"2028-10",{"name":5,"class":6}]